CenterBook Partners LP Has $2.76 Million Stock Position in Axon Enterprise, Inc $AXON

CenterBook Partners LP lessened its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 32.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 4,863 shares of the biotechnology company’s stock after selling 2,345 shares during the quarter. CenterBook Partners LP’s holdings in Axon Enterprise were worth $2,762,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Creative Financial Designs Inc. ADV bought a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $28,000. New Millennium Group LLC bought a new position in shares of Axon Enterprise in the third quarter valued at approximately $29,000. Sound Income Strategies LLC raised its position in shares of Axon Enterprise by 550.0% in the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after purchasing an additional 44 shares during the period. Camelot Portfolios LLC bought a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $30,000. Finally, Lodestone Wealth Management LLC bought a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $35,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Down 3.1%

AXON opened at $471.06 on Tuesday. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $885.91. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.27 and a quick ratio of 1.93. The firm’s fifty day moving average price is $408.45 and its two-hundred day moving average price is $491.12. The company has a market capitalization of $37.97 billion, a P/E ratio of 189.18, a P/E/G ratio of 8.84 and a beta of 1.45.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. The firm had revenue of $807.35 million for the quarter, compared to the consensus estimate of $778.91 million. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The business’s revenue was up 33.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.47 earnings per share. On average, analysts anticipate that Axon Enterprise, Inc will post 1.82 EPS for the current year.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, CRO Cameron Brooks sold 1,242 shares of Axon Enterprise stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $500.00, for a total transaction of $621,000.00. Following the completion of the transaction, the executive directly owned 49,710 shares of the company’s stock, valued at approximately $24,855,000. This trade represents a 2.44% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 2,000 shares of Axon Enterprise stock in a transaction on Friday, May 22nd. The shares were sold at an average price of $400.00, for a total value of $800,000.00. Following the transaction, the insider directly owned 52,813 shares of the company’s stock, valued at approximately $21,125,200. The trade was a 3.65% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 39,344 shares of company stock valued at $19,267,315. Insiders own 4.20% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on AXON shares. Piper Sandler lowered their price objective on shares of Axon Enterprise from $690.00 to $674.00 and set an “overweight” rating on the stock in a research note on Thursday, May 7th. Royal Bank Of Canada lowered their price objective on shares of Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 25th. Wall Street Zen upgraded shares of Axon Enterprise from a “sell” rating to a “hold” rating in a research note on Saturday, February 28th. The Goldman Sachs Group set a $535.00 price objective on shares of Axon Enterprise in a research note on Thursday, May 7th. Finally, UBS Group lowered their price objective on shares of Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a research note on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and an average price target of $712.75.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.